BioStock: Iconovo establishes Nordic pharmaceutical sales

Iconovo has started building up the subsidiary Iconovo Pharma, which will sell and market pharmaceuticals in the Nordic region. Inhalation products are a natural focus area for Iconovo Pharma, but they may also consider including other products if both the product and business model are attractive. The portfolio will consist of in-licensed, complex generic products and proprietary inhalation products. The first proprietary product in the portfolio is expected to be a generic equivalent of AstraZeneca’s blockbuster Symbicort Turbuhaler. BioStock contacted Fredrik Radencrantz, Director Business Development, to find out more about the plans for Iconovo Pharma.

Read the full article at biostock.se:

https://www.biostock.se/en/2022/12/iconovo-establishes-nordic-pharmaceutical-sales/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se